Search results

  1. A

    Which statistical tests are appropriate for estimating drug treatment effects in a crossover design (transition from medication to placebo)?

    Ok, I will plan this and see how it goes, and how it can be analyzed with further tests. Regards
  2. A

    Which statistical tests are appropriate for estimating drug treatment effects in a crossover design (transition from medication to placebo)?

    Thanks so much! This example gave me good clarity about few things. Just worried about how to go about the baseline measurements. Or just work with difference in the measurements. I know there is a lot of debate on this, and most of the people I know prefer to work with actual followup...
  3. A

    Which statistical tests are appropriate for estimating drug treatment effects in a crossover design (transition from medication to placebo)?

    Just wondering what all analysis would be meaningful and work towards setting up a complete report on this data. A. Timepoints T1, T2 and T3; B. Groups: A2P (Active medication T1 to T2; Placebo T2 to T1) and P2A (opposite pattern of A2P). C. Response variables: C1. Scalar...
  4. A

    Which statistical tests are appropriate for estimating drug treatment effects in a crossover design (transition from medication to placebo)?

    MMSE is a series of 30 questions testing of orientation, attention, memory, language and visual-spatial skills. Please note it is just one score; there are several other such cognitive/functional/behavioural scores recorded which I am interested in testing. Additionally, I would like to see if...
  5. A

    Which statistical tests are appropriate for estimating drug treatment effects in a crossover design (transition from medication to placebo)?

    Yes, randomized. The mental state was formatted as a contiguous score (for example, MMSE: Mini Mental State Exam.) ..
  6. A

    Which statistical tests are appropriate for estimating drug treatment effects in a crossover design (transition from medication to placebo)?

    Hi all! I am interested in estimating drug treatment effects in a crossover design where I have a baseline, week 20 and week 40 measurements (1. univariate; 2. multivariate) for a set of 30 patients. 15 of these patients were treated with active medication during the first phase (baseline to...